FDA Inspection 1119496 — Vitalant
The FDA completed an inspection of Vitalant on Feb 6, 2020 in Schaumburg, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 6, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Schaumburg, IL (United States)